Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DENND3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | DENND3 |
| Key Genes/Proteins | AND, CDC42, CYCS, DIABETES MELLITUS, GENES, GFAP |
| Related Diseases | Diabetes, Inflammation |
graph TD
DENND3["DENND3"]
DENND3 -->|"upregulates"| Type_2_Diabetes_Mellitus_with_["Type 2 Diabetes Mellitus with Parkinson's Disease"]
DENND3 -->|"involved_in"| Immune_Response["Immune Response"]
DENND3 -->|"target for"| Parkinson["Parkinson"]
DENND3 -->|"target for"| Diabetes["Diabetes"]
DENND3 -->|"regulates"| AND["AND"]
DENND3 -->|"regulates"| GENES["GENES"]
DENND3 -->|"regulates"| RAC1["RAC1"]
DENND3 -->|"target for"| NCF1["NCF1"]
MGA["MGA"] -->|"regulates"| DENND3
TPM2["TPM2"] -->|"regulates"| DENND3
RAC1 -->|"regulates"| DENND3
GENES -->|"regulates"| DENND3
HUB_GENES["HUB GENES"] -->|"regulates"| DENND3
VIM["VIM"] -->|"target for"| DENND3
GFAP["GFAP"] -->|"target for"| DENND3
MMP9["MMP9"] -->|"target for"| DENND3| Target | Relation | Type | Str |
|---|---|---|---|
| Type 2 Diabetes Mellitus with Parkinson's Disease | upregulates | disease | 0.80 |
| Immune Response | involved_in | process | 0.75 |
| Inflammation | associated_with | disease | 0.65 |
| Diabetes | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| MMP9 | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| MGA | regulates | gene | 0.60 |
| TPM2 | regulates | gene | 0.60 |
| CDC42 | therapeutic_target | gene | 0.60 |
| CYCS | therapeutic_target | gene | 0.60 |
| VIM | therapeutic_target | gene | 0.60 |
| MET | therapeutic_target | gene | 0.60 |
| GFAP | therapeutic_target | gene | 0.60 |
| NCF1 | therapeutic_target | gene | 0.60 |
| Oxidative Stress | therapeutic_target | pathway | 0.60 |
| SOD2 | therapeutic_target | gene | 0.60 |
| Oxidative Stress | associated_with | pathway | 0.60 |
| AND | regulates | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| CDC42 | associated_with | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| GFAP | associated_with | gene | 0.60 |
| SOD2 | associated_with | gene | 0.60 |
| MMP9 | associated_with | gene | 0.60 |
| CYCS | associated_with | gene | 0.60 |
| RAC1 | regulates | gene | 0.60 |
| DIABETES MELLITUS | associated_with | gene | 0.60 |
| MET | associated_with | gene | 0.60 |
| HUB GENES | regulates | gene | 0.60 |
| VIM | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| NCF1 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TPM2 | associated_with | gene | 0.70 |
| GFAP | associated_with | gene | 0.60 |
| DIABETES MELLITUS | associated_with | gene | 0.60 |
| VIM | associated_with | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | associated_with | gene | 0.60 |
| CYCS | associated_with | gene | 0.60 |
| MGA | regulates | gene | 0.60 |
| TPM2 | regulates | gene | 0.60 |
| RAC1 | regulates | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| CDC42 | associated_with | gene | 0.60 |
| SOD2 | associated_with | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| MMP9 | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| MET | associated_with | gene | 0.60 |
| NCF1 | associated_with | gene | 0.60 |
| VIM | therapeutic_target | gene | 0.60 |
| HUB GENES | regulates | gene | 0.60 |
| GFAP | therapeutic_target | gene | 0.60 |
| MMP9 | therapeutic_target | gene | 0.60 |
| CYCS | therapeutic_target | gene | 0.60 |
| SOD2 | therapeutic_target | gene | 0.60 |
| NCF1 | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| MET | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning DENND3 in their description or question text
No additional research found